IMNN
What one share of Imunon holds
Pharmaceutical Preparations
Imunon’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$3.56 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$3.68 |
| Cash and investments | $1.47 |
| Book value | $0.90 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $14.75 | −$612.05 | $1.14 | −$492.07 | — | — |
| 2018 | $6.40 | −$152.07 | $1.77 | −$91.88 | — | $249.25 |
| 2019 | $5.15 | −$173.66 | $3.60 | −$212.38 | — | $140.86 |
| 2020 | $3.52 | −$151.24 | $0.13 | −$110.09 | — | $102.88 |
| 2021 | $1.38 | −$57.41 | $0.86 | −$45.70 | — | $145.04 |
| 2022 | $1.05 | −$75.39 | $0.56 | −$49.07 | — | $59.16 |
| 2023 | — | −$32.36 | $0.75 | −$32.29 | — | $21.36 |
| 2024 | — | −$16.94 | $0.03 | −$17.18 | — | $4.39 |
| 2025 | — | −$6.83 | $0.13 | −$6.68 | — | $2.07 |